bioMérieux has obtained CE-marking for its LUMED™ APSS™ software

General News

▤ Summary

bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of LUMED™ APSS™, an advanced clinical decision support system (CDSS) designed to enhance antimicrobial stewardship programs (ASP) and improve patient outcomes. They enable faster and more accurate identification of pathogens and resistance mechanisms, allowing healthcare providers to make data-driven decisions and select the most effective treatments promptly. LUMED™ APSS™ is a software solution designed for infectious disease (ID) pharmacists and physicians as an aid to address the challenges of antimicrobial overuse and misuse, which contribute to the rise of drug-resistant organisms. The solution also includes support and training for medical teams to ensure a seamless implementation of LUMED™ APSS™ and help them adopt best practices in antibiotic therapy. This system not only supports optimal antimicrobial prescribing but also helps improve patient safety and reduce healthcare costs3," stated Dr Charles K. Cooper, Executive Vice President, Chief Medical Officer, bioMérieux.

▥ Classifications

industries
HealthTech
applications
Data Management

◇ AskAI Classifications

Labels
Healthcare Software Laboratory Information Systems Industrial Software

▦ Linked Companies